PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2025-01-08

Date Title Company
08-Jan-2025 Onco-Innovations Provides Information Regarding Exclusive License for Patented Drug with Potential to Enhance Cancer Treatment Options AccessWire
08-Jan-2025 NextGen Healthcare Named Top Physician Practice Management Vendor by Black Book Research(TM) AccessWire
08-Jan-2025 BIAL Announces First Patient Out in its Phase 2 Clinical Trial of BIA 28-6156 - a Novel Therapy for GBA1 Parkinson's Disease BIAL
08-Jan-2025 Model N Appoints New Chief Executive Officer, Bret Connor Model N
08-Jan-2025 Applied DNA Reschedules Investor Update Call in Observance of the National Day of Mourning in Recognition of the Passing of Former President Jimmy Carter AccessWire
08-Jan-2025 NHI Announces Updates to Corporate Governance AccessWire
08-Jan-2025 Switzerland’s Basel Region Crowned ‘Europe’s Top Destination to Launch a Drug Device Company’, According to Pharmapack Report Pharmapack
08-Jan-2025 Essex Management Appoints David Loose as Chief Executive Officer Appointment Reflects Commitment to Continuing Essex’s Strategic Vision ROCKVILLE, MD Emmes
08-Jan-2025 Supreme Group Acquires Curator24, Adding Sixth Agency to Best-In-Class Healthcare Service Platform Supreme Group
08-Jan-2025 Biotech Startups Get a Boost: ZAGENO and Hatch.Bio Labs Partner to Streamline Lab Operations Newswire
08-Jan-2025 STRATEC TO PARTICIPATE IN THE 43RD ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE STRATEC SE
08-Jan-2025 PureTech to Present at 43rd Annual J.P. Morgan Healthcare Conference PureTech
08-Jan-2025 uniQure Announces Pricing of its Public Offering uniQure
08-Jan-2025 Tiziana Life Sciences Announces Review Article Published in Nature Highlighting Foralumab's Potential in the Treatment of Neurological Disease Tiziana Life Sciences
08-Jan-2025 iTeos to Present at the 43rd Annual J.P. Morgan Healthcare Conference iTeos Therapeutics
08-Jan-2025 "Annotatability" is a New Method to Decode How AI Learns to Label Developed by Hebrew University Researchers Hebrew University of Jerusalem
08-Jan-2025 Formycon and Fresenius Kabi Canada receive Health Canada’s approval for FYB202/Otulfi® (ustekinumab), a biosimilar to Stelara® Formycon AG
08-Jan-2025 ProBioGen Expands Protein and Viral Manufacturing to Drive Continued Growth ProBioGen
08-Jan-2025 Angelini Ventures co-leads €20 million Series A financing in Neumirna Therapeutics to Develop Next-Generation RNA Therapeutics for Epilepsy and other Neurological Disorders Angelini Ventures
08-Jan-2025 Cambridge Cognition highlights positive CANTAB® results in research by Bristol Myers Squib Cambridge Cognition